Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancer
Abstract
Antagonism of arginine vasopressin receptor 1a inhibits growth of emergent, established, and bone metastatic castration-resistant prostate cancer.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jun 26, 2019
- Source ID
- 10.1126/scitranslmed.aaw4636
Entities
People
- Ann M. Greene
- Cale D Fahrenholtz
- Chen-Hao Lo
- Conor C Lynch
- Fiorella Magani
- Kerry L Burnstein
- Laine M Heidman
- Maria Julia Martinez
- Meghan A Rice
- Ning Zhao
- Stephanie O Peacock
- Valeria A Copello
- Yehia Daaka
- Yushan Zhang
Organizations
- H. Lee Moffitt Cancer Center & Research Institute
- Sylvester Comprehensive Cancer Center
- United States Department of Defense
- University of Florida
- University of Miami
- Urology Care Foundation
- Wallace H. Coulter Foundation